Maelstrom and Animoca Capital join forces to strategically invest in BioProtocol to build AI+biotechnology+cryptocurrency triangle ecosystem

According to Bijie.com, decentralized science platform Bio Protocol has received US$6.9 million in financing from Maelstrom Fund and Animoca Brands, aiming to expand the AI ​​protophysiology research framework. The platform integrates blockchain and AI technology, accelerates drug research and development through tokenized incentive mechanisms, and shortens the traditional funding cycle. Founder Arthur Hayes said it is expected to become a "incubation platform that defines industry categories."